EE223 Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.472
https://www.valueinhealthjournal.com/article/S1098-3015(22)02676-6/fulltext
Title :
EE223 Economic Consequences of Administering Obinutuzumab as a Short Duration Infusion in Italian Patients With Advanced Follicular Lymphoma: A Cost Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02676-6&doi=10.1016/j.jval.2022.09.472
First page :
Section Title :
Open access? :
No
Section Order :
12281